To evaluate the Anti-dandruff efficacy of test products in healthy Indian human - None

nilever Industries Pvt Ltd0 个研究点目标入组 207 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Female and male subjects in the ratio of 2:1 in general good health.
•2.Subjects in the age group 18-42 years (both the ages inclusive).
•3.Subjects willing to give a written informed consent and agree to come for a regular follow up visit.
•4.Subjects willing to abide by and comply with the study protocol.
•5.Subjects who have not participated in a similar investigation in the past three months.
•6.Subjects who agree to refrain from using hair dye / hair colour /henna during the study period.
•7.Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration
•8.Subjects who agree not to change their regular regimen (including hair oils)

•1.Subjects who have undergone hair growth treatment within 3 months before screening into the study.
•2.Subjects having any active scalp disease which may interfere in the study Ã¢â?¬â?? dermatologistÃ¢â?¬•s judgement.
•3.Subjects (male) having androgenic alopecia, male pattern baldnessÃ¢â?¬• not be included in study.
•4.Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
•5.Subjects (females) who are pregnant or lactating
•6.Subjects who have had hair transplant.
•7.A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
•8.Chronic illness which may influence the cutaneous state.
•9.Subjects participating in other similar cosmetic or therapeutic trial within last three months
•10.Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
•11.Subjects (males) who are having androgenic alopecia, male pattern baldness.

发起方

nilever Industries Pvt Ltd